• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在老年和幼年人群中合并感染的发病机制:解读免疫脆弱性的不祥故事

Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability.

作者信息

Mai Kai-Lin, Pan Wei-Qi, Lin Zheng-Shi, Wang Yang, Yang Zi-Feng

机构信息

Henan University College of Medicine, Kaifeng, 475004, China.

School of Life Sciences, Henan University, Kaifeng, 475004, China.

出版信息

Adv Biotechnol (Singap). 2025 Jan 21;3(1):5. doi: 10.1007/s44307-025-00057-9.

DOI:10.1007/s44307-025-00057-9
PMID:39883362
Abstract

The co-circulation of influenza and SARS-CoV-2 has led to co-infection events, primarily affecting children and older adults, who are at higher risk for severe disease. Although co-infection prevalence is relatively low, it is associated with worse outcomes compared to mono-infections. Previous studies have shown that the outcomes of co-infection depend on multiple factors, including viral interference, virus-host interaction and host response. Children and the elderly exhibit distinct patterns of antiviral response, which involve airway epithelium, mucociliary clearance, innate and adaptive immune cells, and inflammatory mediators. This review explores the pathogeneses of SARS-CoV-2 and influenza co-infection, focusing on the antiviral responses in children and the elderly. By comparing immature immunity in children and immune senescence in older adults, we aim to provide insights for the clinical management of severe co-infection cases.

摘要

流感和新型冠状病毒(SARS-CoV-2)的共同流行导致了合并感染事件,主要影响儿童和老年人,他们患重症的风险更高。尽管合并感染的发生率相对较低,但与单一感染相比,其预后更差。先前的研究表明,合并感染的结果取决于多种因素,包括病毒干扰、病毒与宿主的相互作用以及宿主反应。儿童和老年人表现出不同的抗病毒反应模式,这涉及气道上皮、黏液纤毛清除、固有免疫和适应性免疫细胞以及炎症介质。本综述探讨了SARS-CoV-2与流感合并感染的发病机制,重点关注儿童和老年人的抗病毒反应。通过比较儿童的不成熟免疫和老年人的免疫衰老,我们旨在为重症合并感染病例的临床管理提供见解。

相似文献

1
Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability.流感与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在老年和幼年人群中合并感染的发病机制:解读免疫脆弱性的不祥故事
Adv Biotechnol (Singap). 2025 Jan 21;3(1):5. doi: 10.1007/s44307-025-00057-9.
2
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
3
Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.流感病毒感染的离散动力学模型表明免疫存在年龄依赖性差异。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.00395-17. Print 2017 Dec 1.
4
Pathophysiology of COVID-19: Why Children Fare Better than Adults?COVID-19 的病理生理学:儿童为何比成人预后更好?
Indian J Pediatr. 2020 Jul;87(7):537-546. doi: 10.1007/s12098-020-03322-y. Epub 2020 May 14.
5
Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease.SARS-CoV-2 感染后肺泡巨噬细胞中的抗病毒先天免疫记忆可改善二次甲型流感病毒疾病。
Immunity. 2024 Nov 12;57(11):2530-2546.e13. doi: 10.1016/j.immuni.2024.08.018. Epub 2024 Sep 30.
6
Counterintuitive effect of antiviral therapy on influenza A-SARS-CoV-2 coinfection due to viral interference.抗病毒治疗因病毒干扰对甲型流感病毒与严重急性呼吸综合征冠状病毒2型合并感染产生的反直觉效应。
bioRxiv. 2023 Feb 8:2023.02.07.527372. doi: 10.1101/2023.02.07.527372.
7
Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.人器官型气道和肺泡分化的肺类器官细胞允许流感和 SARS-CoV-2 呼吸道病毒感染。
Front Cell Infect Microbiol. 2022 Mar 14;12:841447. doi: 10.3389/fcimb.2022.841447. eCollection 2022.
8
A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.一种新型载姜黄素的薄膜喷雾能抑制 SARS-CoV-2 和流感病毒感染并增强黏膜免疫。
Virol J. 2024 Jan 23;21(1):26. doi: 10.1186/s12985-023-02282-x.
9
Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.COVID-19 免疫发病机制中的树突状细胞:对其在决定疾病结局中可能起作用的深入了解。
Int Rev Immunol. 2021;40(1-2):108-125. doi: 10.1080/08830185.2020.1844195. Epub 2020 Nov 16.
10
Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis.COVID-19 中先天免疫和适应性免疫反应相互作用的数学建模及其对病毒发病机制的影响。
J Med Virol. 2020 Sep;92(9):1615-1628. doi: 10.1002/jmv.25866. Epub 2020 May 13.

引用本文的文献

1
Viral Infections in Elderly Individuals: A Comprehensive Overview of SARS-CoV-2 and Influenza Susceptibility, Pathogenesis, and Clinical Treatment Strategies.老年人中的病毒感染:SARS-CoV-2和流感易感性、发病机制及临床治疗策略的全面概述
Vaccines (Basel). 2025 Apr 21;13(4):431. doi: 10.3390/vaccines13040431.
2
Exploration of the impact of air pollutants on the influenza epidemic after the emergence of COVID-19: based on Jiangsu Province, China (2020-2024).新冠疫情出现后空气污染物对流感流行影响的探索:基于中国江苏省(2020 - 2024年)
Front Public Health. 2025 Apr 14;13:1555430. doi: 10.3389/fpubh.2025.1555430. eCollection 2025.

本文引用的文献

1
A decavalent composite mRNA vaccine against both influenza and COVID-19.一种针对流感和 COVID-19 的十价复合 mRNA 疫苗。
mBio. 2024 Sep 11;15(9):e0066824. doi: 10.1128/mbio.00668-24. Epub 2024 Aug 6.
2
Defining the balance between optimal immunity and immunopathology in influenza virus infection.确定流感病毒感染中最佳免疫与免疫病理之间的平衡。
Nat Rev Immunol. 2024 Oct;24(10):720-735. doi: 10.1038/s41577-024-01029-1. Epub 2024 May 2.
3
Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
SARS-CoV-2 与流感病毒体外共感染的相互作用及抗病毒治疗。
Virus Res. 2024 Jul;345:199371. doi: 10.1016/j.virusres.2024.199371. Epub 2024 Apr 18.
4
Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.人表面活性剂蛋白 A 抑制 SARS-CoV-2 感染性并减轻小鼠感染模型中的肺损伤。
Front Immunol. 2024 Mar 26;15:1370511. doi: 10.3389/fimmu.2024.1370511. eCollection 2024.
5
Severe pneumonia with co-infection of H5N1 and SARS-CoV-2: a case report.严重肺炎合并 H5N1 和 SARS-CoV-2 感染:一例报告。
BMC Infect Dis. 2024 Jan 2;24(1):31. doi: 10.1186/s12879-023-08901-w.
6
SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".SARS-CoV-2 与先天免疫:好、坏与“恰到好处”。
Cell Mol Immunol. 2024 Feb;21(2):171-183. doi: 10.1038/s41423-023-01104-y. Epub 2023 Nov 20.
7
The role of cell death in SARS-CoV-2 infection.细胞死亡在 SARS-CoV-2 感染中的作用。
Signal Transduct Target Ther. 2023 Sep 20;8(1):357. doi: 10.1038/s41392-023-01580-8.
8
Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.甲型流感病毒-严重急性呼吸综合征冠状病毒 2 型在人呼吸道上皮细胞中的病毒干扰作用及奥司他韦的逆转作用。
J Infect Dis. 2024 May 15;229(5):1430-1434. doi: 10.1093/infdis/jiad402.
9
Prevalence and associated outcomes of coinfection between SARS-CoV-2 and influenza: a systematic review and meta-analysis.SARS-CoV-2 与流感共感染的流行率及相关结局:系统评价和荟萃分析。
Int J Infect Dis. 2023 Nov;136:29-36. doi: 10.1016/j.ijid.2023.08.021. Epub 2023 Aug 28.
10
Inflammation and aging: signaling pathways and intervention therapies.炎症与衰老:信号通路与干预治疗。
Signal Transduct Target Ther. 2023 Jun 8;8(1):239. doi: 10.1038/s41392-023-01502-8.